Browsing by Author Davies, Lucy

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 8 of 8
Issue DateTitleAuthor(s)Citation
2017Bevacizumab with or after chemotherapy for platinum-resistant recurrent ovarian cancer: Exploratory analyses of the AURELIA trialDavies, Lucy; Gebski, Val; Gibbs, Emma; Lee, C.; Veillard, Anne-Sophie; Bamias, A; Bloemendal, H; Dimopoulos, M; Floquet, A.; Kosse, J; Lykka, M; Mirza, Mansoor Raza; Pujade-Lauraine, Eric; santaballa, A; Tabaro, G; Vergote, I; Zagouri, F; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreBevacizumab with or after chemotherapy for platinum-resistant recurrent ovarian cancer: Exploratory analyses of the AURELIA trial, Annals of Oncology, vol.28, 8, 2017,pp 1842-1848
2015Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: The ALaCaRT randomized clinical trialDavies, Lucy; Gebski, Val; Hague, Wendy; Simes, Robert John; Solomon, Michael; Wilson, Kate; Clouston, Andrew; Hewett, Peter; Lumley, John; Stevenson, Andrew R. L.; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Central Clinical School: Surgery; NH&MRC Clinical Trials CentreEffect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: The ALaCaRT randomized clinical trial, JAMA: The Journal of the American Medical Association, vol.314, 13, 2015,pp 1356-1363
2017Effect of total laparoscopic hysterectomy vs total abdominal hysterectomy on disease-free survival among women with stage i endometrial cancer: A randomized clinical trialBrand, Alison; Davies, Lucy; Gebski, Val; Hogg, Russell; Pather, Selvan; et al, Various; Forder, P; Janda, Monica; Jobling, Thomas W.; Land, R; Manolitsas, Tom; Nascimento, M; Neesham, D; Nicklin, J; Oehler, M; Western Clinical School: Medicine (Westmead); NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead); Central Clinical School: MedicineEffect of total laparoscopic hysterectomy vs total abdominal hysterectomy on disease-free survival among women with stage i endometrial cancer: A randomized clinical trial, JAMA: The Journal of the American Medical Association, vol.317, 12, 2017,pp 1224-1233
2017Gefitinib or erlotinib vs chemotherapy for EGFR mutation-positive lung cancer: individual patient data meta-analysis of overall survivalDavies, Lucy; Gebski, Val; Lee, Chee Khoon; Lord, Sarah (Sally); Marschner, Ian; Fukuoka, Masahiro; Gralla, Richard J; Inoue, Akira; Mitsudomi, Tetsuya; Mok, Tony; Nakagawa, Kazuhiko; Rosell, Rafael Costa; Thongprasert, Sumitra; Tu, Yu-Kang; Wu, Yi-long; Yang, James; Zhou, Caicun; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreGefitinib or erlotinib vs chemotherapy for EGFR mutation-positive lung cancer: individual patient data meta-analysis of overall survival, Journal of the National Cancer Institute, vol.109, 6, 2017,pp 1-13
2016Nonsyndromic Thoracic Aortic Aneurysm and Dissection: Outcomes With Marfan Syndrome Versus Bicuspid Aortic Valve AneurysmAndvik, Sarah; Bannon, Paul; Davies, Lucy; Jeremy, Richmond; Keech, Anthony (Tony); Padang, Ratnasari; Sherrah, Andrew; Vallely, Michael; van der Linde, Denise; Wilson, Michael; Central Clinical School: Medicine; Central Clinical School: Surgery; NH&MRC Clinical Trials Centre; Central Clinical School: Medicine; NH&MRC Clinical Trials Centre; Central Clinical School: Medicine; Central Clinical School: Surgery; Central Clinical School: Surgery; Central Clinical School: Medicine; Central Clinical School: SurgeryNonsyndromic Thoracic Aortic Aneurysm and Dissection: Outcomes With Marfan Syndrome Versus Bicuspid Aortic Valve Aneurysm, Journal of the American College of Cardiology, vol.67, 6, 2016,pp 618-626
2016Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptor-positive breast cancer (ANZ0501 LATER): An open-label randomised, controlled trialCoates, Alan; Davies, Lucy; Gebski, Val; Bayliss, E; Boyle, F M; Della-Fiorentina, S; et al, Various; Forbes, John F.; Gill, P Grantley; Kannourakis, G; Kling, N; Saunders, Christobel; Zdenkowski, Nicholas; School of Public Health: Public Health; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreObservation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptor-positive breast cancer (ANZ0501 LATER): An open-label randomised, controlled trial, Annals of Oncology, vol.27, 5, 2016,pp 806-812
2017Quality of life predicts overall survival in women with platinum-resistant ovarian cancer: an AURELIA substudyAsher, Rebecca; Davies, Lucy; Gebski, Val; Gibbs, Emma; King, Madeleine; Lee, Chee Khoon; Roncolato, Felicia; Stockler, Martin; Friedlander, Michael; Hilpert, Felix; Pujade-Lauraine, Eric; Wenzel, Lari; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Psychology; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreQuality of life predicts overall survival in women with platinum-resistant ovarian cancer: an AURELIA substudy, Annals of Oncology, vol.28, 8, 2017,pp 1849-1855
2016Serum human epidermal growth factor 2 extracellular domain as a predictive biomarker for lapatinib treatment efficacy in patients with advanced breast cancerDavies, Lucy; Gebski, Val; Lee, Chee Khoon; Lord, Sarah (Sally); Marschner, Ian; Simes, Robert John; Cameron, David; de Souza, Paul; Di Leo, Angelo; Ellis, Catherine; Geyer, Charles; Johnston, Stephen; Loi, Sherene; Press, Michael F.; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreSerum human epidermal growth factor 2 extracellular domain as a predictive biomarker for lapatinib treatment efficacy in patients with advanced breast cancer, Journal of Clinical Oncology, vol.34, 9, 2016,pp 936-944